| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 9 | +77.78% | -1.44% | +0.50% | -1.94% | -3.04% | — |
| 14d | 9 | +55.56% | -3.64% | -0.50% | -3.15% | -4.23% | — |
| 30d | 9 | +55.56% | -10.58% | +0.83% | -11.41% | -12.49% | — |
| 60d | 9 | +66.67% | -11.42% | -0.48% | -10.94% | -13.23% | — |
| 90d | 9 | +66.67% | -20.15% | -0.79% | -19.36% | -18.40% | — |
| 180d | 9 | +55.56% | -15.19% | +9.96% | -25.15% | -15.48% | — |
| 1y | 9 | +88.89% | -42.49% | +22.29% | -64.78% | -52.10% | — |
| 2y | 9(2 pending) | +85.71% | -83.61% | +45.41% | -129.03% | -134.21% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 80,300 | — | — | 80,300 | Jan 23, 2025 | Jan 27, 2025 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 40,150 | — | — | 251,708 | Jan 23, 2025 | Jan 27, 2025 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 15,936 | $11.20 | $178.5K | 211,558 | Jan 17, 2025 | Jan 22, 2025 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 9,900 | $11.56 | $114.4K | 227,494 | Jul 10, 2024 | Jul 12, 2024 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 19,337 | — | — | 237,394 | Jul 9, 2024 | Jul 11, 2024 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 31,500 | — | — | 216,569 | Jan 23, 2024 | Jan 24, 2024 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 63,000 | — | — | 63,000 | Jan 23, 2024 | Jan 24, 2024 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 9,786 | $17.23 | $168.6K | 185,069 | Jan 17, 2024 | Jan 19, 2024 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Business Officer | 8,791 | $2.08 | $18.3K | 214,905 | Aug 4, 2023 | Aug 7, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 20,050 | $20.01 | $401.2K | 194,855 | Aug 4, 2023 | Aug 7, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Business Officer | 8,791 | — | — | 31,367 | Aug 4, 2023 | Aug 7, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Business Officer | 1,800 | $2.08 | $3.7K | 207,914 | Aug 3, 2023 | Aug 7, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE10b5-1 10b5-1 plan | 1,800 | $20.00 | $36.0K | 206,114 | Aug 3, 2023 | Aug 7, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Business Officer | 1,800 | — | — | 40,158 | Aug 3, 2023 | Aug 7, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 13,069 | $20.00 | $261.4K | 206,114 | Aug 3, 2023 | Aug 7, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 17,937 | $18.01 | $323.0K | 219,183 | Jul 17, 2023 | Jul 19, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 35,156 | — | — | 237,120 | Jul 14, 2023 | Jul 18, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 9,036 | $26.52 | $239.6K | 201,964 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 17,578 | — | — | 211,000 | Mar 29, 2023 | Mar 31, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 76,200 | — | — | 76,200 | Jan 25, 2023 | Jan 27, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 54,000 | — | — | 192,191 | Jan 25, 2023 | Jan 27, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Business Officer | 8,748 | $19.10 | $167.1K | 138,191 | Dec 20, 2022 | Dec 21, 2022 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 17,578 | — | — | 146,939 | Dec 19, 2022 | Dec 21, 2022 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 112,500 | — | — | 112,500 | Jan 26, 2022 | Feb 2, 2022 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Business Officer | 4,500 | $2.08 | $9.4K | 125,246 | May 26, 2021 | May 28, 2021 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Business Officer | 4,500 | — | — | 12,979 | May 26, 2021 | May 28, 2021 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 62,250 | — | — | 62,250 | Jan 23, 2021 | Jan 26, 2021 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Business Officer | 3,500 | $2.08 | $7.3K | 120,746 | Dec 30, 2020 | Jan 4, 2021 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Business Officer | 3,500 | — | — | 17,479 | Dec 30, 2020 | Jan 4, 2021 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Business Officer | 27,322 | — | — | 0 | Jun 5, 2020 | Jun 9, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Business Officer | 3,821 | — | — | 3,821 | Jun 5, 2020 | Jun 9, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Business Officer | 36,319 | — | — | 0 | Jun 5, 2020 | Jun 9, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Business Officer | 5,079 | — | — | 117,246 | Jun 5, 2020 | Jun 9, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 70,352 | — | — | 70,352 | Mar 31, 2020 | Jun 9, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 27,322 | $13.08 | $357.5K | 27,322 | Feb 28, 2020 | Jun 9, 2020 ↗ | View → |